Cargando…
Two randomized controlled clinical trials to study the effectiveness of prednisolone treatment in preventing and restoring clinical nerve function loss in leprosy: the TENLEP study protocols
BACKGROUND: Nerve damage in leprosy often causes disabilities and deformities. Prednisolone is used to treat nerve function impairment (NFI). However, optimal dose and duration of prednisolone treatment has not been established yet. Besides treating existing NFI it would be desirable to prevent NFI....
Autores principales: | Wagenaar, Inge, Brandsma, Wim, Post, Erik, van Brakel, Wim, Lockwood, Diana, Nicholls, Peter, Saunderson, Paul, Smith, Cairns, Wilder-Smith, Einar, Richardus, Jan Hendrik |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3547773/ https://www.ncbi.nlm.nih.gov/pubmed/23249098 http://dx.doi.org/10.1186/1471-2377-12-159 |
Ejemplares similares
-
The Missing Millions: A Threat to the Elimination of Leprosy
por: Smith, William Cairns, et al.
Publicado: (2015) -
Comparing the Clinical and Histological Diagnosis of Leprosy and Leprosy Reactions in the INFIR Cohort of Indian Patients with Multibacillary Leprosy
por: Lockwood, Diana N. J., et al.
Publicado: (2012) -
Early detection of neuropathy in leprosy: a comparison of five tests for field settings
por: Wagenaar, Inge, et al.
Publicado: (2017) -
Effectiveness of 32 versus 20 weeks of prednisolone in leprosy patients with recent nerve function impairment: A randomized controlled trial
por: Wagenaar, Inge, et al.
Publicado: (2017) -
Early Diagnosis of Neuropathy in Leprosy—Comparing Diagnostic Tests in a Large Prospective Study (the INFIR Cohort Study)
por: van Brakel, Wim H., et al.
Publicado: (2008)